Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
FEBS J. 2022 Dec;289(24):7740-7759. doi: 10.1111/febs.16192. Epub 2021 Sep 29.
Hematopoietic stem cells (HSCs) give rise to all types of blood cells and self-renew their own population. The regeneration potential of HSCs has already been successfully translated into clinical applications. However, recent studies on the biology of HSCs may further extend their clinical use in future. The roles of HSCs in native hematopoiesis and in transplantation settings may differ. Furthermore, the heterogenic pool of HSCs dynamically changes during aging. These changes also involve the complex interactions of HSCs with the bone marrow niche. Here, we review the opportunities and challenges of these findings to improve the clinical use of HSCs. We describe new methods of HSCs mobilization and conditioning for the transplantation of HSCs. Finally, we highlight the research findings that may lead to overcoming the current limitations of HSC transplantation and broaden the patient group that can benefit from the clinical potential of HSCs.
造血干细胞(HSCs)可分化为所有类型的血细胞,并自我更新其群体。HSCs 的再生潜力已成功转化为临床应用。然而,最近对 HSCs 生物学的研究可能会进一步扩展其未来的临床应用。HSCs 在天然造血和移植环境中的作用可能不同。此外,HSCs 的异质性池在衰老过程中会动态变化。这些变化还涉及 HSCs 与骨髓龛之间的复杂相互作用。在这里,我们回顾了这些发现带来的机遇和挑战,以改善 HSCs 的临床应用。我们描述了用于 HSCs 移植的 HSCs 动员和调理的新方法。最后,我们强调了可能导致克服 HSC 移植当前局限性并扩大受益于 HSCs 临床潜力的患者群体的研究发现。